BML Capital Management, LLC Diversified Active

Name: BML Capital Management, LLC Q2 2026 13F Filing | 13F Explorer
Creator: BML Capital Management, LLC
Published: 2026-08-07

Location: Zionsville, IN

CIK: 0001616824 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 7, 2026

Total Value: $176M (100.0% shares, 0.0% debt)

Holdings (18)

New Positions (3)

ENGN ENGENE THERAPEUTICS INC 6.6%

Value $11.54M Shares 6,669,908 Est. Cost $1.73 Unrealized —

CORZ CORE SCIENTIFIC INC NEW 0.2%

Value $298K Shares 800 Est. Cost — Unrealized —

TSLA TESLA INC 0.2%

Value $270K Shares 375 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ENGN	ENGENE THERAPEUTICS INC	6,669,908	$11.54M	6.6%	$1.73	—	COM A	29286X101
CORZ	CORE SCIENTIFIC INC NEW	800	$298K	0.2%	—	—	PUT	21874A106
TSLA	TESLA INC	375	$270K	0.2%	—	—	PUT	88160R101

Increased Positions (4)

KHC KRAFT HEINZ CO 6.2%

Value $10.98M (+290.7%) Shares 465,000 (+272.0%) Est. Cost $23.70 Unrealized —

OM OUTSET MED INC 6.2%

Value $10.89M (+49.0%) Shares 2,519,701 (+32.5%) Est. Cost $5.33 Unrealized —

KMX CARMAX INC 5.2%

Value $9.124M (+41.6%) Shares 172,500 (+11.3%) Est. Cost $41.30 Unrealized —

CNTB CONNECT BIOPHARMA HLDGS LTD 0.8%

Value $1.364M (+27.4%) Shares 573,287 (+40.2%) Est. Cost $1.95 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
KHC	KRAFT HEINZ CO	465,000 (+272.0%)	$10.98M (+290.7%)	6.2%	$23.70	—	COM	500754106
OM	OUTSET MED INC	2,519,701 (+32.5%)	$10.89M (+49.0%)	6.2%	$5.33	—	COM NEW	690145206
KMX	CARMAX INC	172,500 (+11.3%)	$9.124M (+41.6%)	5.2%	$41.30	—	COM	143130102
CNTB	CONNECT BIOPHARMA HLDGS LTD	573,287 (+40.2%)	$1.364M (+27.4%)	0.8%	$1.95	—	SHS	G23549101

Exited Positions (1)

KZR KEZAR LIFE SCIENCES INC 3.0%

Value $5.348M Shares 720,787 Est. Cost $5.37 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
KZR	KEZAR LIFE SCIENCES INC	720,787	$5.348M	3.0%	$5.37	—	—	49372L209

Decreased Positions (3)

ACRS ACLARIS THERAPEUTICS INC 36.0%

Value $63.35M (+18.5%) Shares 11,975,000 (-16.0%) Est. Cost $1.28 Unrealized —

ORMP ORAMED PHARMACEUTICALS INC 2.4%

Value $4.167M (-61.3%) Shares 866,269 (-72.6%) Est. Cost $2.32 Unrealized —

AVIR ATEA PHARMACEUTICALS INC 18.4%

Value $32.33M (-14.9%) Shares 6,952,330 (-1.5%) Est. Cost $3.51 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	ACLARIS THERAPEUTICS INC	11,975,000 (-16.0%)	$63.35M (+18.5%)	36.0%	$1.28	—	COM	00461U105
ORMP	ORAMED PHARMACEUTICALS INC	866,269 (-72.6%)	$4.167M (-61.3%)	2.4%	$2.32	—	COM NEW	68403P203
AVIR	ATEA PHARMACEUTICALS INC	6,952,330 (-1.5%)	$32.33M (-14.9%)	18.4%	$3.51	—	COM	04683R106

Unchanged Positions (8)

PMVP PMV PHARMACEUTICALS INC 4.1%

Value $7.142M Shares 5,330,000 Est. Cost $1.49 Unrealized —

TIL INSTIL BIO INC 2.8%

Value $4.965M Shares 645,600 Est. Cost $17.47 Unrealized —

TGT TARGET CORP 2.8%

Value $4.898M Shares 37,500 Est. Cost $92.99 Unrealized —

TLYS TILLYS INC 5.1%

Value $9.03M Shares 2,150,000 Est. Cost $1.57 Unrealized —

JANX JANUX THERAPEUTICS INC 1.4%

Value $2.38M Shares 154,961 Est. Cost $13.66 Unrealized —

PLRX PLIANT THERAPEUTICS INC 1.0%

Value $1.763M Shares 1,546,137 Est. Cost $1.50 Unrealized —

IMA IMAGENEBIO INC 0.7%

Value $1.184M Shares 200,730 Est. Cost $12.50 Unrealized —

WMT WALMART INC 0.2%

Value $386K Shares 335 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PMVP	PMV PHARMACEUTICALS INC	5,330,000	$7.142M	4.1%	$1.49	—	COM	69353Y103
TIL	INSTIL BIO INC	645,600	$4.965M	2.8%	$17.47	—	COM NEW	45783C200
TGT	TARGET CORP	37,500	$4.898M	2.8%	$92.99	—	COM	87612E106
TLYS	TILLYS INC	2,150,000	$9.03M	5.1%	$1.57	—	CL A	886885102
JANX	JANUX THERAPEUTICS INC	154,961	$2.38M	1.4%	$13.66	—	COM	47103J105
PLRX	PLIANT THERAPEUTICS INC	1,546,137	$1.763M	1.0%	$1.50	—	COM	729139105
IMA	IMAGENEBIO INC	200,730	$1.184M	0.7%	$12.50	—	COM	45175G207
WMT	WALMART INC	335	$386K	0.2%	—	—	PUT	931142103